THC BioMed Announces First Quarter Release Date
THC BioMed Intl Ltd. announces that it will release its Q1 2021 financial statements for the period ending October 31, 2021, after market hours on November 30, 2021. As one of Canada’s oldest licensed cannabis companies, THC BioMed has been producing medical and recreational cannabis since 2013 and is focusing on leading the beverage and edible segments. The company aims to leverage its research capabilities in a rapidly growing industry.
- Established presence as one of Canada's oldest licensed cannabis companies.
- Focus on leading the beverage and edible segments indicates potential for growth.
- No financial metrics were provided in the announcement, leaving investors in the dark about performance.
THC.CSE THCBF - OTC TFHD.F
VANCOUVER, BC, Nov. 30, 2021 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") announces that it intends to release its Q1 2021 financial statements for the period ended October 31, 2021 after market hours on November 30, 2021.
About THC
THC BioMed is one of Canada's oldest active licensed cannabis companies. It was first licensed to deal with cannabis in 2013 under a Health Canada Section 56 exemption under the Controlled Drugs and Substances Act and has been a Licensed Producer under the current regime since 2016. It aims to be a leader in the beverage and edible space.
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that THC BioMed will be on the forefront of this rapidly growing industry. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thc-biomed-announces-first-quarter-release-date-301433658.html
SOURCE THC BioMed
FAQ
When will THC BioMed release its Q1 2021 financial statements?
What period do the Q1 2021 financial statements cover for THC BioMed?
What is THC BioMed's focus in the cannabis market?
When did THC BioMed first become licensed to deal with cannabis?
